Asosiy kontentga oʻtish
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

378 ta ish

Ish: Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

  1. Hallmarks of Cancer: The Next Generation

    Douglas Hanahan, Robert A. Weinberg

    Sharh maqolaOchiq kirish201122 iqtibos
    ABI
  2. Targeting cancer stem cell pathways for cancer therapy

    Liqun Yang, Pengfei Shi, Gaichao Zhao +8

    Sharh maqolaOchiq kirish20205 iqtibos
    ABI
  3. mTOR: a pharmacologic target for autophagy regulation

    Young Chul Kim, Kun‐Liang Guan

    Sharh maqolaOchiq kirish20154 iqtibos
    ABI
  4. Targeting non-coding RNAs to overcome cancer therapy resistance

    Baoqing Chen, Mihnea P. Dragomir, Yang Chen +3

    Sharh maqolaOchiq kirish20224 iqtibos
    ABI
  5. Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

    Yujie Li, Qin Jiang, Guo-Fan Cao +2

    Sharh maqolaOchiq kirish20153 iqtibos
    ABI
  6. mTOR Signaling in Growth, Metabolism, and Disease

    Robert A. Saxton, David M. Sabatini

    Sharh maqolaOchiq kirish20173 iqtibos
    ABI
  7. The Role of mTOR Signaling as a Therapeutic Target in Cancer

    N. V. Popova, Manfred Jücker

    Sharh maqolaOchiq kirish20213 iqtibos
    ABI
  8. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets

    Mengshu You, Zhuolin Xie, Nan Zhang +6

    Sharh maqolaOchiq kirish20233 iqtibos
    ABI
  9. Macrophages in immunoregulation and therapeutics

    Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu +5

    Sharh maqolaOchiq kirish20233 iqtibos
    ABI
  10. Sarlavhasiz

    Boshqa3 iqtibos
    ABI
  11. Sarlavhasiz

    BoshqaOchiq kirish2 iqtibos
    ABI
  12. Sarlavhasiz

    BoshqaOchiq kirish2 iqtibos
    ABI
  13. mTOR Signaling in Growth Control and Disease

    Mathieu Laplante, David M. Sabatini

    Sharh maqolaOchiq kirish20122 iqtibos
    ABI
  14. Autophagy, cancer stem cells and drug resistance

    Alexandra G. Smith, Kay F. Macleod

    Sharh maqolaOchiq kirish20182 iqtibos
    ABI
  15. Targeting PI3K in cancer: mechanisms and advances in clinical trials

    Jing Yang, Ji Nie, Xuelei Ma +3

    Sharh maqolaOchiq kirish20192 iqtibos
    ABI